ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,827.04
-1.54%
Dow Jones
41,938.45
-1.63%
US Dollar vs MXN
20.8129
0.48%
Brent Oil
80.54
-0.09%
Bitcoin
91,801.13
-2.85%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Carmell Corporation (CTCX)

  7. Carmell Corporation (CTCX) Noticias

Carmell Corporation

Carmell Corporation (CTCX)

NASDAQ
0.492328
0.07223
(17.19%)
Cerrado 10 Enero 3:00PM
Delayed by 15 minutes
0.4333
-0.05903
( -11.99% )
Pre Mercado: 4:12AM
Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Premium

CTCX Noticias

Solo noticias oficiales

Form 8-K - Current report
Edgar (US Regulatory)
05 Enero 2024
CTCX (17.19%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
19 Diciembre 2023
CTCX (17.19%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
18 Diciembre 2023
CTCX (17.19%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
18 Diciembre 2023
CTCX (17.19%)

CTCX Discussion

Ver más
glenn1919 glenn1919 2 semanas hace
ctcx.......................weeeeeeeeeeeeeeeeeeeeeeeeee
👍️0
declaes declaes 2 semanas hace
The volume in the past few days was telling  I hope you all got in 🤑
👍️0
Invest-in-America Invest-in-America 2 semanas hace
CTCX: Bust that damn DOLLAR!!!
👍️0
Invest-in-America Invest-in-America 2 semanas hace
CTCX: Kick that ASK!!!!!
👍️0
Invest-in-America Invest-in-America 2 semanas hace
CTCX: My E-Turd gave me BIG problems, simply tryin' to grab this rocket ship today!! I DID get a decent price, but COULD have grabbed it like an insider at the PR firm just before they launched the NEWS!!! (I know, that's illegal --- but I wish I was only age 21 right now, & workin' at "GlobeNewswire" PR desk, for example!!! E.g., "Hello, MOM, grab a bunch of CTCX for us right now!!! I'm gonna tap the PR launch button in circa 10-minutes!!!")
👍️0
tw0122 tw0122 2 semanas hace
Yes acquiring $ELAB $2.41 assets .72 +'156% 
👍️0
Invest-in-America Invest-in-America 2 semanas hace
CTCX: Good news!!
👍️0
glenn1919 glenn1919 3 semanas hace
CTCX...............https://stockcharts.com/h-sc/ui?s=CTCX&p=W&b=5&g=0&id=p86431144783
👍️0
tw0122 tw0122 3 semanas hace
8 million shares priced at .23 for commercial launch 
👍️0
tw0122 tw0122 3 semanas hace
1.8 private placemt and up it goes .47 + 110%
👍️0
glenn1919 glenn1919 1 mes hace
ctcx......https://stockcharts.com/h-sc/ui?s=CTCX&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 2 meses hace
CTCX, new 52 week low
👍️0
glenn1919 glenn1919 3 meses hace
CTCX..............................https://stockcharts.com/h-sc/ui?s=CTCX&p=W&b=5&g=0&id=p86431144783
👍️0
tw0122 tw0122 3 meses hace
.56 + 16% Run run another pump whoops might be too late lol
👍️0
Invest-in-America Invest-in-America 3 meses hace
CTCX: And STILL under $2.00.

_____________________________________________________________________
I'm producing a film, "American Cars of 1908" --- tap link below for latest edition:
https://i.giphy.com/media/v1.Y2lkPTc5MGI3NjExOXVyb2N1NXVkejE5em04cDMyYnRvbDV2ejAzeHdsdmZzc2JxajQwZSZlcD12MV9pbnRlcm5hbF9naWZfYnlfaWQmY3Q9Zw/f1NTdkdbG4XzW/giphy.gif
👍️0
glenn1919 glenn1919 3 meses hace
CTCX...................................https://stockcharts.com/h-sc/ui?s=CTCX&p=W&b=5&g=0&id=p86431144783
👍️0
Awl416 Awl416 3 meses hace
Oh cmon
👍️0
frans frans 3 meses hace
CTCX 0.53 X 0.53
👍️0
tw0122 tw0122 3 meses hace
Ok .50 now
👍️0
Monksdream Monksdream 6 meses hace
CTCX under $2
👍️0
Monksdream Monksdream 6 meses hace
CTCX under $2
👍️0
stock1ace1 stock1ace1 1 año hace
Carmell Announces Successful Closing of Merger with Axolotl Biologix and Launch of a New Brand Identity

https://www.businesswire.com/news/home/20230809916251/en/Carmell-Announces-Successful-Closing-of-Merger-with-Axolotl-Biologix-and-Launch-of-a-New-Brand-Identity
👍️0
stock1ace1 stock1ace1 1 año hace
CTCX $2.90 #merger complete rsi 22 oversold macd crossover bullish

https://stockcharts.com/h-sc/ui?s=Ctcx
👍️0
AJ Freely AJ Freely 1 año hace
$CTCX - Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company
Up 57% Pre-Market/ Current Price $4.74
👍️0
Monksdream Monksdream 1 año hace
Carmell Therapeutics Corp NASDAQ: CTCX*

GoSymbol lookup
*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements
Health Care : Biotechnology | Company profile
Carmell Therapeutics Corporation is a regenerative medicine platform company. The Company is engaged in the development of allogeneic plasma-based bioactive material (PBM) that is designed to boost innate regenerative pathways across a variety of bone and soft tissue indications. The PBM technology is licensed from Carnegie Mellon University and claims the ability to plasticize whole plasma and cross link with genipin, a derivative of the gardenia plant, to provide a controlled degradation profile in vivo. The Company’s lead product, CT-101 Bone Healing Accelerant (BHA), a biologic, is designated by the United States Food and Drug Administration (FDA) as a combination product, containing the Company’s core technology of PBM plus B Tri-Calcium Phosphate (B-TCP) an already approved medical device. The Company has FDA clearance for a Phase II-stage clinical trial designed to study accelerated healing and reduced infections in open tibia (shinbone) fractures with intramedullary rodding.
Carmell Therapeutics Corp NASDAQ: CTCX*

GoSymbol lookup
*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements
Health Care : Biotechnology | Company profile
Carmell Therapeutics Corporation is a regenerative medicine platform company. The Company is engaged in the development of allogeneic plasma-based bioactive material (PBM) that is designed to boost innate regenerative pathways across a variety of bone and soft tissue indications. The PBM technology is licensed from Carnegie Mellon University and claims the ability to plasticize whole plasma and cross link with genipin, a derivative of the gardenia plant, to provide a controlled degradation profile in vivo. The Company’s lead product, CT-101 Bone Healing Accelerant (BHA), a biologic, is designated by the United States Food and Drug Administration (FDA) as a combination product, containing the Company’s core technology of PBM plus B Tri-Calcium Phosphate (B-TCP) an already approved medical device. The Company has FDA clearance for a Phase II-stage clinical trial designed to study accelerated healing and reduced infections in open tibia (shinbone) fractures with intramedullary rodding.
👍️0

Su Consulta Reciente

NASDAQ
CTCX
Carmell
LSE
FM49
Natwest.m 28
BIT
SYS
Sys Dat
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados